Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 24, 2014 FBO #4534
SOURCES SOUGHT

66 -- Laser Ablation System

Notice Date
4/22/2014
 
Notice Type
Sources Sought
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
 
ZIP Code
20857-0001
 
Solicitation Number
1130748
 
Archive Date
5/22/2014
 
Point of Contact
Sondea R Blair, Phone: 8705437469
 
E-Mail Address
sondea.blair@fda.hhs.gov
(sondea.blair@fda.hhs.gov)
 
Small Business Set-Aside
N/A
 
Description
MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION This is a sources sought to determine the availability and capability of small businesses to provide a Laser Ablation System. The associated North American Industry Classification System (NAICS) Code is 334516- Analytical Laboratory Instrument Manufacturing; Small Business Size Standard is 500 employees. Part I: General Information (Introduction/Background/Scope) The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Food Safety and Applied Nutrition (CFSAN) requirement for a Laser Ablation System with up to four (4) 1-Year Option periods for post warranty maintenance. The FDA's Chemical Contaminants Branch (CHCB) is responsible for development of FDA methods to test for toxic elements in the US food supply. The CHCB intends to use a Laser Ablation System interfaced with an Inductively Coupled Plasma Mass Spectrometer (ICP-MS) System to provide direct sampling and spatial distribution information of major, minor, and trace elements in variety of food samples, dietary supplements, and cookware. The Government intends to use the Laser Ablation System coupled with an ICP-MS for the purpose of analyzing elemental composition of powders from various foods and dietary supplements within minutes, at trace and ultra-trace levels, providing high throughput (200+ samples per day) with minimal staffing (one technician). The process shall eliminate the use of concentrated acids and chemicals thus minimizing cost of chemicals, reducing operational safety risks, and eliminating hazardous waste. Part II: Work Requirements A. Minimum Technical Requirements At a minimum, the system shall: • Be compatible with the Government's existing Inductively Coupled Mass Spectrometer Systems and corresponding software: Agilent Technologies 7700x, serial number JP10290507, and Thermo Scientific Element2, serial number 04028E, as well as other ICP-MS Systems • Manage a minimum of 200 samples per day • Operate with one technician • Contain a 193 nm short pulse laser • Include a laser spot size: minimum range of 5 - 150 micrometer (a minimum of 15 spot sizes) • Include a 100mm x 100mm two volume sample chamber with sub-micron stage resolution • Include a homogenized beam delivery system • Have a continuously variable attenuator energy control • Have a minimum of 1 mass flow controller • Include software provisions and trigger control for Agilent 7700x and Thermo Element2 ICP-MS systems • Be capable of 1-100 Hz laser repetition rate • Include an automated nitrogen purge with automated shutoff • Be equipped gas block for automated argon fluoride gas exchange • Include an integrated energy meter with active energy stabilization • Have a high magnification zoom, video microscope • Include software controlled coaxial, ring and transmitted lighting • Include Independent video and lasing optical element for optimal viewing and crater quality B. Turn-Key System Offerors are expected to provide a turn-key solution which shall include, but not be limited to: • All hardware, components, interfaces, cables, instrument computers, software, on-site familiarization and operation required to meet these specifications and the FDA's stated need and intended use for these systems. C. Inside Delivery, Installation, and Training • The contractor shall provide inside delivery, installation, and clean-up of the installation site for the entire system with documented Installation/Operational Qualification, validation, and on-site training • Installation shall be inclusive of all labor, parts, installation kits, and travel expense • Training shall be inclusive of contractor labor, materials, and travel expense D. Minimum Service Requirements I. Warranty System shall be inclusive of a minimum 12-month warranty inclusive of parts, labor, and travel expense to commence upon installation, training, and acceptance of the equipment II. Post-Warranty Maintenance At a minimum, the Contractor shall provide the following services during the option periods for post-warranty periods: -One (1) scheduled preventive maintenance visit annually inclusive of parts, travel, and labor expense. - Include unlimited corrective/remedial maintenance visits within 3 business days of call for service. - Include unlimited technical support, Mondays - Fridays (excluding Federal Holidays) between the hours of 7:00 AM - 5:00 PM Eastern Time, within 8 business hours of contact for assistance (e.g., telephone-based, email-based, website-based, etc.) - Include unlimited software and firmware updates. - All maintenance and repair activities shall be performed by trained and certified technicians/engineers, following Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins, using OEM replacement parts, components, subassemblies, etc. - Access for the FDA Contracting Officer's Representative (COR) and system operator personnel to the manufacturer's call center for technical assistance, which is staffed by senior engineers to provide a high level of expertise for troubleshooting the instrument. -Inclusive of labor, travel, replacement parts, components, subassemblies, etc. The offeror may provide information on multiple types of service agreements plans available. Part III: Supporting Information A. Place of Performance Shall be delivered to: U.S. Food and Drug Administration 5100 Paint Branch Parkway College Park, MD 20740 B. Period of Performance System delivery and installation shall be completed within 90 calendar days from date of award. Part III: Instructions to Prospective Respondents The offeror shall furnish sufficient technical information necessary for the Government to conclusively determine that the offered instrument and components meet the technical requirements identified above. - At a minimum provide: All descriptive material necessary for the government to determine whether the product offered meets the technical requirements including technical specifications, descriptive material, literature, brochures and other information, which demonstrates the capabilities of the contractor to meet the requirement. Indicate whether the organization is the manufacturer of the items or authorized reseller. If reseller, include the manufacturer's name, address and DUNS number. - Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; - Three (3) years of past performance information for the same or substantially similar items, to include date of services, description (should also include technical literature and specifications), dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; - Descriptive literature, brochures, specifications, marketing material, etc. detailing the nature of the services the responding firm is regularly engaged in providing; - If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; - Although this is not a request for quote, informational pricing is encouraged; The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested parties must respond with capability statements, which are due in person, by postal mail or email to the point of contact listed below on or before May 7, 2014 by 4:00 PM (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OO|OFBA|OAGS|DAP, Attn: Sondea Blair, 3900 NCTR Road, Bldg 50/Room 421, HFT‐320, Jefferson, AR 72079‐9502 or email sondea.blair@fda.hhs.gov. Reference #1130748 in all correspondence with the point of contact listed above. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether this requirement should be set aside for small business, made available to full and open competition or procured through other than full and open acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis/solicitation (No. FDA-13-223-SOL-1130748) may be published via FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1130748/listing.html)
 
Place of Performance
Address: US Food and Drug Administration, 5100 Paint Branch Parkway, College Park, Maryland, 20740, United States
Zip Code: 20740
 
Record
SN03344923-W 20140424/140422234633-62db55e4ab26054e37c41faf11fcd407 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.